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Association of severe hypertension with pneumonia
in elderly patients with acute ischemic stroke
Keiichiro Ishigami, Masashi Okuro, Yumi Koizumi, Kazuto Satoh, Osamu Iritani, Hiroshi Yano,
Toshihiro Higashikawa, Kunimitsu Iwai and Shigeto Morimoto
Pneumonia is one of the most frequent complications in elderly patients with acute ischemic stroke. Although severe
hypertension is often observed in the early phase of acute stroke, there are few studies of acute hypertension as a factor
inﬂuencing the incidence of stroke-associated pneumonia (SAP) in elderly subjects with acute ischemic stroke. To assess the
association of acute phase blood-pressure elevation with the incidence of SAP, we compared 10 elderly patients with acute
ischemic stroke complicated with severe hypertension (X200/120mmHg) with 43 patients with moderate hypertension
(160–199/100–119mmHg), as well as with 65 control normotensive or mildly hypertensive (o160/100mmHg) controls
on admission. Data were collected on known risk factors, type of ischemic stroke and underlying chronic conditions. The
signiﬁcance of differences in risk factors was analyzed using univariate and multivariate comparisons of 38 SAP cases and
others, 8 SAP death cases and others, and 28 patients with poor outcome associated with in-hospital death or artiﬁcial feeding
at discharge and others. After adjustment for potential confounding factors, the relative risk estimates for SAP, SAP death and
poor outcome were 2.83 (95% conﬁdence interval 1.14–7.05), 5.20 (1.01–26.8) and 6.84 (1.32–35.4), respectively, for
severe hypertension relative to normotensive or mildly hypertensive controls. We conclude that severe hypertension on admission
is an independent predictive factor for SAP in elderly patients with acute ischemic stroke.
Hypertension Research (2012) 35, 648–653; doi:10.1038/hr.2012.7; published online 9 February 2012
Keywords: elderly; ischemic stroke; pneumonia; severe hypertension
INTRODUCTION
Stroke-associated pneumonia (SAP) is among the leading complica-
tions of stroke,1–11 and is an important cause of death after cerebro-
vascular events.1,3,4 SAP is most likely to develop in patients who are
seriously ill and those with dysphagia. There are various data available
on independent predictors of SAP in treated acute stroke patients. In
those studies, a number of risk factors have been reported, such as
lower baseline Glasgow Coma Scale score,4–6 dysphagia,7–9 male
sex,3,7,9,10 stroke subtype,8,9 diabetes,10 ischemic heart disease9 and
chronic congestive heart failure.11 SAP is known to occur more
frequently in elderly patients,2,3,9–11 although conﬂicting results are
also reported.4 Besides SAP, severe arterial hypertension is another
frequent medical complication observed in patients with acute
ischemic stroke within the ﬁrst week after admission.12–16 This
increased blood pressure (BP) falls spontaneously within the ﬁrst
week, without speciﬁc antihypertensive therapy.17 Severe hypertension
in the early phase of acute ischemic stroke is another sign associated
with poor functional outcome and higher mortality.18–20 As yet,
however, there are only limited data on the association of SAP with
severe arterial hypertension in patients with acute stroke. We here
present a study of SAP in elderly patients admitted to our hospital
with acute ischemic stroke associated with severe hypertension
with systolic BP (SBP) X200mmHg and/or diastolic BP (DBP)
X120mmHg on admission.21 The results were compared with
those in elderly patients with acute ischemic stroke with moderate
hypertension with SBP 160–199mmHg and/or DBP 100–119mmHg,
who may develop signs of encephalopathy,22 and with normotensive




Consecutive patients admitted to the Geriatric Emergency Ward of Kanazawa
Medical University Hospital, a major urban hospital in Ishikawa Prefecture,
Japan, with a diagnosis of ischemic stroke during 2002–2010 were recruited
into the study. Patients participating in this study were 70 years of age or older,
and had both clinical and neuroimaging evidence of ischemic cerebral infarc-
tion. Only patients with symptom onset within 24h of admission were
included in this study. All subjects were systematically evaluated. Neurovascular
evaluation, including assessment of underlying chronic conditions, serial
neurological examinations including Glasgow Coma Scale, 12-lead electrocar-
diograms, chest X-ray examination and transthoracic echocardiograms, in
addition to routine hematologic and chemistry tests were completed in all
subjects. The presence of dysphagia was screened in all the study subjects. For
this, clinical examination and a water swallowing test with pulse oximetry were
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www.nature.com/hrperformed, and a drop in arterial oxygen saturation of 42% within 2min after
swallowing was considered clinically signiﬁcant to detect dysphagia with silent
aspiration or cough.23 Dysphagia with impaired voice or complete dysphagia
without swallowing was also considered to indicate the presence of dysphagia.
During this period, vital signs, including noninvasive cuff BP, pulse rate and
body temperature, were measured at least every 2h during the ﬁrst 24h and
continued every 2–8h up to 72h. Antihypertensive medication was given at the
discretion of physicians not involved in the study, who in general followed the
recommendations of the Guidelines for the Management of Hypertension
published in 2009 by the Japanese Society of Hypertension Committee (JSH
2009)24 for BP of 220/120mmHg and higher. The patients were divided into
three groups according to the record of the highest mean SBP and/or DBP of
two measurements every 2h during the ﬁrst 24h after admission; control
patients with normotension to mild hypertension (SBP o160mmHg and DBP
o100mmHg), patients with moderate hypertension (SBP 160–199mmHg
and/or DBP 100–119mmHg) and those with severe hypertension (SBP
X200mmHg and/or DBP X120mmHg).
Assessment of brain lesions
All patients underwent brain magnetic resonance imaging and magnetic
resonance angiography on the ﬁrst day of admission. Imaging was performed
using a 1.5-T MRI (Model: MAGNETOM Avanto, Siemens Medical Solution,
Erlangen, Germany). Acute ischemic lesions were assessed by diffusion-
weighted imaging with apparent diffusion coefﬁcient. Ischemic lesions on
diffusion-weighted imaging were classiﬁed as single lesions (corticosubcortical
lesion, cortical lesion, subcortical lesion with diameter 415mm or subcortical
lesion with diameter o15mm), scattered lesions in one vascular territory
(small (o15mm) scattered lesions or conﬂuent (415mm) lesions with an
additional lesion) and multiple lesions in multiple vascular territories (in the
unilateral anterior circulation, posterior circulation, bilateral anterior circula-
tion or anterior and posterior circulation). Stroke subtype classiﬁcation was
performed according to a previous report.25 Patients with diffusion-weighted
imaging imaging ﬁndings of a corticosubcortical single lesion and those with
multiple lesions in both the anterior and posterior circulation were classiﬁed as
having cardiac embolism if they had atrial ﬁbrillation and/or another cardi-
oembolic source. Those with subcortical small lesion(s) (o15mm) were
classiﬁed as having small-vessel occlusion. Those with subcortical lesion(s)
(o20mm) were also classiﬁed as having small-vessel occlusion according to the
recommendations in the report.25 Other patients with atrial ﬁbrillation and/or
another cardioembolic sources were classiﬁed as having cardiac embolism.
Patients without a cardioembolic source were classiﬁed as having large-artery
atherosclerosis. Patients with transient ischemia with no visible lesion on
diffusion-weighted imaging were excluded from this study.
Underlying chronic conditions
We observed the clinical features of the enrolled patients, including past history
of stroke, ischemic heart disease, chronic congestive heart failure, chronic
kidney disease, diabetes mellitus and hypertension under treatment with an
antihypertensive agents. Operational deﬁnitions of each preexisting chronic
condition were established prior to data collection, including past history of
stroke (evidence of chronic phase of stroke on magnetic resonance imaging),
ischemic heart disease (evidence on electrocardiography or echocardiography),
chronic congestive heart failure (left ventricular ejection fraction p40%),
chronic kidney disease (estimated glomerular ﬁltration rate with coefﬁcients
modiﬁed for Japanese patients:26 194 Cr 1.094 age 0.287 ( 0.739 if female)
o60mlmin 11.73m 2), diabetes mellitus (use of hypoglycemic agents and/or
insulin) and hypertension (use of antihypertensive agents).
Deﬁnitions of SAP and poor outcome
Patients with (without) SAP are referred to as SAP+ (SAP ) patients. The
deﬁnition of SAP includes either the clinical ﬁnding of rales or dullness to
percussion and one of the following: purulent sputum, isolation of the
organism, chest radiograph showing evidence of an inﬁltrate/consolidation/
cavitation or pleural effusion, and one of the following: purulent sputum,
isolation of the agent or antibody evidence of an agent.7 Deﬁnition of SAP
death was deﬁned as death in SAP patients during in-hospital treatment. The
deﬁnition of poor outcome was either in-hospital death or artiﬁcial feeding at
discharge. Patients who had a prior history of dysphagia before the index
stroke and those who required mechanical ventilation during the hospital stay
were excluded. Patients who had another identiﬁable source of infection before
the development of pneumonia and those who had fever before stroke onset
were also excluded.
Statistical methods
For comparing cases and controls, we used univariate analyses including w2 test
(Fisher’s exact test when needed) for comparing categorical variables and
nonparametric Mann–Whitney U statistics for comparing the distributions of
ordinal variables. Continuous variables were compared among the three
hypertensive states by one-way ANOVA, with Tukey’s test for post-hoc compar-
isons. The distribution of serum C-reactive protein level was positively skewed,
and was therefore log transformed before statistical comparison. Results were
then expressed in natural units for ease of interpretation. Discrete variables
were reported as percentages and compared by w2 analysis. Logistic regression
analysis was used to identify factors independently associated with SAP after
adjustment for confounding variables. Common pitfalls associated with multi-
variate regression were avoided as described by Cibcati et al.27 The odds ratio
(OR) for severe hypertension associated with various conditions was calculated
by logistic regression analysis, adjusting for age, sex and all associated variables
selected according to their univariate analysis P-value (Po0.10). Estimates for
OR and corresponding two-sided 95% conﬁdence interval (CI) demonstrating
statistical signiﬁcance were derived from the regression model. Data were
analyzed using SPSS (v. 16.0, Chicago, IL, USA). A probability of Po0.05 was
taken as statistically signiﬁcant.
RESULTS
Study population
A total of 118 patients (mean age 84 6±5.4 years, range 72–96 years;
58 men, 85.0±5.1 years; 60 women, 84.2±5.7 years) with complete
ischemic stroke were included. The mean duration of treatment was
25.7±7.2 days (range 1–109 days). Hemispheric infarction was
documented in 104 (88%) patients, with more than one hemispheric
territory affected in 14 of them. According to the results of magnetic
resonance imaging, 62 patients were classiﬁed as having large-artery
atherosclerosis, 22 small-vessel occlusion and 34 cardiac embolism.
Characteristics of SAP
SAP occurred in 38 (30.5%) out of 118 patients, with a mean latency
from admission of 1.8±2.7 days (range 0–12 days). These 38 SAP+
patients were compared with 80 SAP  patients (Table 1). SAP+
patients had higher mean SBP compared with SAP  patients
(166±31 vs. 150±28mmHg, P¼0.006), higher mean pulse BP
(80±22 vs. 69±20mmHg, P¼0.018), lower Glasgow Coma Scale
score (11.8±3.4 vs. 13.6±2.6, P¼0.001), higher WBC count
(8.13±2.55 vs. 6.08±1.42 1012l 1, Po0.001), higher serum
C-reactive protein (7.9 with s.d. range 1.5–40.9 vs. 3.8 with s.d.
range 1.0–6.0, Po0.001) and higher incidence of dysphagia (44.7%
vs. 15.0%, P¼0.001) on admission. However, there was no signiﬁcant
difference in age, sex, type of ischemic stroke or underlying chronic
conditions including prior use of antihypertensive agents (Table 1).
Clinical predictors of SAP
The Glasgow Coma Scale score was signiﬁcantly higher in both the
moderate hypertensive group and severe hypertensive group than in
the control group. WBC count was also signiﬁcantly higher in the
severe hypertensive group, and the incidence of dysphagia was
signiﬁcantly higher in the moderately hypertensive group than in
the control group. The clinical background, frequency of underlying
chronic conditions and previous use of antihypertensive medication
were similar in the three hypertensive states, although previous use of
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cantly higher than that in normotensive/mildly hypertensive controls
(Table 2).
Logistic regression analysis using age, sex, Glasgow Coma Scale
score, WBC count, log(serum C-reactive protein), dysphagia and
hypertensive state as confounding factors revealed that log(serum
C-reactive protein) (OR: 1.89, 95% CI: 1.26–2.85, P¼0.002), WBC
count (OR: 1.47, 95% CI: 1.11–1.95, P¼0.008) and hypertensive state
(OR: 2.27, 95% CI: 1.04–4.97, P¼0.040) were independently and
signiﬁcantly associated with an increased risk of SAP. Conditional
logistic regression analysis revealed a signiﬁcantly higher risk of SAP in
those with severe hypertension, with adjusted OR estimate of 2.83 and
CI 1.14–7.05, with control BP level as the reference group (Table 3).
Even when the previous use of antihypertensive medication was added
as another confounding factor to those above, hypertensive state was
still independently and signiﬁcantly associated with an increased risk
of SAP (OR: 2.26, 95% CI: 1.03–4.94, P¼0.041) by logistic regression
analysis, and a signiﬁcant increase in the risk of SAP in those with
severe hypertension (OR: 2.85, 95% CI: 1.13–7.16, P¼0.026) was still
revealed with control BP level as the reference group by conditional
logistic regression analysis.
SAP death and poor outcome
On the other hand, out of the eight patients with SAP death, three
patients showed severe hypertension, three moderate hypertension
and two control BP levels. Logistic regression analysis using age, sex,
Glasgow Coma Scale score, WBC count, log(serum C-reactive pro-
tein), dysphagia and hypertensive state as confounding factors
revealed that male sex (OR: 23.0, 95% CI: 1.66–319, P¼0.019) and
hypertensive state (OR: 5.69, 95% CI: 1.24–26.1, P¼0.025) were
independently and signiﬁcantly associated with an increased risk of
SAP death. Conditional logistic regression analysis adjusted by the
same confounding factors revealed a signiﬁcant increase in the risk of
SAP death in those with severe hypertension on admission, with an
adjusted OR estimate of 5.20 and CI 1.01–26.8, with control BP level
as the reference group (Table 4). Even when the previous use of
antihypertensive medication was added as another confounding factor
to the above, hypertensive state was still independently and signiﬁ-
cantly associated with an increase risk of SAP death (OR: 5.92, 95%
CI: 1.25–28.1, P¼0.025) by logistic regression analysis, although a
tendency for increased risk of SAP death in those with severe
hypertension (OR: 6.11, 95% CI: 0.84–44.6, P¼0.074) was still
revealed with control BP level as the reference group by conditional
logistic regression analysis.
Besides the 8 patients with SAP death, 3 patients died from other
causes in hospital and 17 patients were receiving artiﬁcial feeding at
discharge. Logistic regression analysis using the same confounding
factors revealed that dysphagia (OR: 65.2, 95% CI: 9.74–437,
Po0.001) and hypertensive state (OR: 5.66, 95% CI: 1.32–24.3,
P¼0.020) were independently and signiﬁcantly associated with an
increased risk of poor outcome associated with in-hospital mortality
and artiﬁcial feeding at discharge. Conditional logistic regression
analysis adjusted by the same confounding factors revealed a signiﬁ-
cant increase in the risk of poor outcome in those with severe
hypertension on admission, with adjusted OR estimate of 6.84 and
CI 1.32–35.4, with control BP level as the reference group (Table 5).
Even when the previous use of antihypertensive medication was added
as another confounding factor to those above, hypertensive state was
still independently and signiﬁcantly associated with an increased risk
of poor outcome (OR: 7.43, 95% CI: 1.24–44.6, P¼0.028) by logistic
regression analysis, and a signiﬁcant increase in the risk of poor
outcome in those with severe hypertension (OR: 9.78, 95% CI: 1.24–
77.4, P¼0.031) was still revealed with control BP level as the reference
group by conditional logistic regression analysis.
DISCUSSION
In this study, we attempted to compare SAP+ patients with SAP 
patients in the acute phase of ischemic stroke and obtain evidence of
predictors of SAP in elderly patients with a mean age of 84.6 years.
Because older age is one of the risk factors for SAP,2,3,9–11 our study
was carried out in one of the most susceptible groups for SAP. Besides
age, we adopted known risk factors for SAP as possible confounding
factors in the present study, such as sex3,7,9,10), Glasgow Coma Scale
score,4–6 dysphagia,7–9 stroke subtype,8,9 diabetes,10 ischemic heart
disease9 and chronic congestive heart failure.11 We also adopted
chronic kidney disease as a factor, because the risk of hospitalization




Age (years) 84.9±5.8 84.4±5.2 0.518
Male: female 22:16 36:44 0.238
Type of ischemic stroke
Large-artery atherosclerosis: n (%) 17 (44.7) 45 (56.3) 0.324
Small-vessel occlusion: n (%) 7 (18.4) 15 (18.8) 0.955
Cardiac embolism: n (%) 14 (36.8) 20 (25.0) 0.198
Clinical ﬁndings on admission
BMI (kgm 2)1 9 . 4 ±3.0 20.0±3.2 0.677
SBP (mmHg) 166±31 150±28 0.006
DBP (mmHg) 87±17 81±19 0.066
Pulse pressure (mmHg) 80±22 69±20 0.018
Glasgow Coma Scale 11.8±3.4 13.6±2.6 0.001
WBC count ( 1012l 1) 8.13±2.55 6.08±1.42 o0.001
Serum C-reactive protein (mgl 1) 7.9 (1.5–40.9) 3.8 (1.0–6.0) o0.001
Serum albumin (gl 1)3 4 . 8 ±4.1 35.7±4.5 0.189
Dysphagia (%) 44.7 15.0 0.001
Underlying chronic conditions
Past history of stroke (%) 34.2 40.0 0.547
Ischemic heart disease (%) 10.5 10.0 0.930
Congestive heart failure (%) 26.3 16.3 0.199
Chronic kidney disease (%) 7.9 8.8 0.877
Diabetes mellitus (%) 23.7 16.3 0.335
Hypertension treatment (%) 26.3 23.8 0.763
ARB alone (%) 5.3 2.5 0.440
ACEI alone (%) 2.6 0 0.147
CaB alone (%) 5.3 8.8 0.507
Thiazide alone (%) 0 1.3 0.491
Two or more antihypertensives (%) 13.2 11.3 0.766
ARB with/without others (%) 13.2 10.0 0.610
ACEI with/without others (%) 7.9 2.5 0.176
CaB with/without others (%) 7.9 16.3 0.217
Thiazide with/without others (%) 10.5 5.0 0.267
Abbreviations: ACEI, angiotensin I-converting enzyme inhibitor; ARB, angiotensin II-receptor
blocker; CaB, dihydropiridine calcium-channel blocker; DBP, diastolic blood pressure; SBP,
systolic blood pressure.
Results for continuous variables are expressed as mean±s.d. and compared using Mann–
Whitney U analysis. Discrete variables are reported as percentages and compared by w2
analysis.
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analysis revealed that elderly SAP+ patients had a signiﬁcantly lower
mean Glasgow Coma Scale score and a higher incidence of dysphagia,
as well as higher WBC count and log(serum C-reactive protein) on
admission, compared with SAP  patients.
In the present study, however, the most notable ﬁnding was the
signiﬁcant association of severe hypertension, deﬁned as 200/
120mmHg or higher, on admission with the occurrence of SAP.
Univariate analysis revealed that elderly SAP+ patients had signiﬁ-
cantly higher SBP and pulse pressure on admission compared with
SAP  patients (Table 1). There were signiﬁcant differences in Glasgow
Coma Scale score, WBC count and incidence of dysphagia among the
three BP groups (Table 2). However, even after adjustment for these
known confounding factors, severe hypertension on admission was
signiﬁcantly and independently associated with SAP, with OR 2.83 and
CI 1.14–7.05, with control BP level as the reference group (Table 3).
The precise mechanism of this association is not known. SAP is
most likely to develop in patients who are seriously ill, and aspiration
due to dysphagia may be one of the most important causes of this
complication. Hypertension in the elderly is a well-known risk factor
for silent cerebral infarction, which is a predictor of not only overt
stroke29 but also aspiration pneumonia due to dysphagia.29,30 On the
other hand, known hypertension before stroke was signiﬁcantly
associated with elevated post-stroke BP.15 In the present study, the
incidence of both dysphagia and known hypertension under treatment
with antihypertensive agents was signiﬁcantly higher in patients with
moderate hypertension on admission compared with normotensive
and/or mildly hypertensive controls (Table 2). Although patients with
Table 2 Characteristics of controls, moderate and severe hypertensives
Controls Moderate hypertensives Severe hypertensives
n¼65 n¼43 n¼10 P-value
Clinical background
Age (years) 84.2±5.8 85.5±4.8 83.5±5.2 0.356
Male: female 36: 29 18: 25 4: 6 0.329
Type of ischemic stroke
Large-artery atherosclerosis: n (%) 34 (52.3) 24 (55.8) 4 (40.0) 0.671
Small-vessel occlusion: n (%) 13 (20.0) 17 (16.3) 2 (20.0) 0.885
Cardiac embolism: n (%) 18 (27.7) 12 (27.9) 4 (40.0) 0.722
Clinical ﬁndings on admission
BMI (kgm 2)1 9 . 9 ±3.1 20.0±3.2 18.1±3.4 0.625
SBP (mmHg) 133.5±18.4 175.0±9.3*** 210.3±13.9***+++ o0.001
DBP (mmHg) 73.9±14.6 90.6±14.9*** 106.7±17.7***+++ o0.001
Pulse pressure (mmHg) 60.5±15.2 83.8±16.5*** 103.4±12.1***+++ o0.001
Glasgow Coma Scale 13.9±3.6 11.9±3.6** 12.2±2.3** 0.002
WBC ( 1012l 1) 6.47±1.81 6.72±2.18 8.59±2.59**+ 0.010
Serum C-reactive protein (mgl 1) 3.6 (0.8–15.1) 3.1 (1.0–10.2) 5.5 (1.9–15.8) 0.471
Serum albumin (gl 1)3 5 . 4 ±4.5 35.2±3.9 36.3±6.2 0.784
Dysphagia (%) 13.6 39.5** 30.0 0.009
Underlying chronic conditions
Past history of stroke (%) 40.0 32.6 50.0 0.540
Ischemic heart disease (%) 6.2 14.0 20.0 0.242
Congestive heart failure (%) 16.9 20.9 30.0 0.603
Chronic kidney disease (%) 6.2 9.3 20.0# 0.339
Diabetes mellitus (%) 15.5 20.9 30.0 0.490
Hypertension treatment (%) 18.5 34.9* 20.0 0.146
ARB alone (%) 3.1 2.3 10.0 0.479
ACEI alone (%) 0 2.3 0 0.422
CaB alone (%) 4.6 11.6 10.0 0.394
Thiazide alone (%) 0 2.3 0 0.422
Two or more antihypertensives (%) 10.8 16.3 0 0.335
ARB with/without others (%) 10.8 14.0 0 0.452
ACEI with/without others (%) 1.5 7.0 10.0 0.254
CAB with/without others (%) 9.2 20.9 10.0 0.212
Thiazide with/without others (%) 6.2 9.3 0 0.555
SAP+ (%) 21.5 39.5# 70.0** 0.004
SAP death (%) 3.1 7.0 30.0*! 0.007
Abbreviations: ACEI, angiotensin I-converting enzyme inhibitor; ARB, angiotensin II-receptor blocker; CaB, dihydropiridine calcium-channel blocker; DBP, diastolic blood pressure; SBP, systolic
blood pressure.
Results for continuous variables are expressed as mean (95% CI) (range) and compared using one-way ANOVA with Tukey’s post-hoc analysis. Discrete variables are reported as percentages and
compared by w2 analysis. Keys as in Table 1. #Po0.10, *Po0.05, **Po0.01 and ***Po0.001 vs. controls. !Po0.10, +Po0.05, ++Po0.01 and +++Po0.001 vs. moderate hypertensives.
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the present study, these observations may indicate that known
hypertension would inﬂuence subclinical swallowing dysfunction
through hypertension-induced brain damage such as silent cerebral
infarction before overt ischemic stroke. However, there was no
signiﬁcant difference in the incidence of dysphagia and known
hypertension between patients with severe hypertension on admission
and patients with control BP. Moreover, conditional logistic regression
analysis revealed a signiﬁcant increase in the risk of SAP in those with
severe hypertension compared with control BP patients, even after
adjustment for dysphagia (Table 3) and known hypertension under
antihypertensive treatment as confounding factors.
Another potential confounder may be drug therapy. ACEI may
decrease the prevalence of aspiration pneumonia in elderly subjects,
probably due to stimulation of the cough reﬂex.31,32 Moreover, several
other antihypertensive agents are reported to modify the risk of
community-acquired pneumonia.33 In the present study, the rate of
antihypertensive treatment prior to ischemic stroke was signiﬁcantly
higher in the moderate hypertension group than in the control group.
However, there was no signiﬁcant difference in the rate of single or
combination use of particular antihypertensive agents between the
severe hypertensive group and either the control group or moderate
hypertensive group. Moreover, there was no signiﬁcant difference in
the rate of single or combined use of particular antihypertensive
agents between SAP+ and SAP  patients. These results indicate that
the effect(s) of any antihypertensive treatment prior to ischemic stroke
on SAP is minimal.
Another possible explanation may be overactivation of the
sympathetic nervous system. Acute severe hypertension in the early
phase of acute ischemic stroke is related to stroke-induced changes
in sympathoadrenergic activity.12,15,34 Dysphagia and subsequent
aspiration are considered to account for the high incidence of bacterial
pneumonia after stroke. However, aspiration alone cannot explain the
high incidence of SAP,35 because aspiration occurs in healthy adults
during sleep without inducing pneumonia.36 The high incidence of
pneumonia in patients with acute ischemic stroke may be due to
stroke-induced immunodeﬁciency primarily caused by overactivation
of the sympathetic nervous system, which was described in mouse
models of cerebral ischemia.37,38 In these animal models, experimental
stroke propagated bacterial aspiration ranging from harmless intra-
nasal colonization to harmful pneumonia, which was exacerbated by
immunodepression due to sympathetic hyperactivity. Moreover,
immediately after admission, chest X-ray inﬁltrate was noted only
in 4 normotensive and/or mildly hypertensive control subjects, but
not in the 7 subjects with severe hypertension on admission, out of the
38 SAP patients in the present study (data not shown). This evidence
may suggest that severe hypertension preceded SAP, at least in
the seven patients, in our study. Although we did not determine
sympathetic activity including circulating levels of catecolamines in
the present study, overactivation of the sympathetic nervous system
could induce both severe hypertension and immunodepression,
resulting in SAP in our elderly ischemic stroke patients. Further,
studies are required to elucidate the precise mechanism of the
association of severe hypertension with SAP.
In the present study, severe hypertension on admission was an
independent predictor not only of SAP but also of SAP death
(Table 4), and of poor outcome associated with in-hospital mortality
and artiﬁcial feeding at discharge (Table 5). Severe hypertension in the
early phase of acute ischemic stroke is a predictor of a poor outcome,
with higher mortality and a poor functional outcome.18–20 Because
SAP is an important cause of death1,3,4 and a worse long-term clinical
outcome,4 the association of severe hypertension with poor outcome
would, at least in part, be explained by higher SAP death and poor
functional outcome in those with severe hypertension revealed in the
present study. However, in view of the small sample size, care must be
taken when these results are interpreted and further evaluation in
larger trials is needed. Moreover, four patients suffered from SAP
already on admission, but remaining 34 patients with SAP were
diagnosed as nosocomial, hospital-acquired pneumonia occurring
during hospitalization. Microbiological examination of tracheal speci-
mens and/or blood cultures did not detected atypical pathogens, such
as Chlamydia pneumoniae, Mycoplasma pneumoniae or Legionella
pneumophila (data not shown), suggesting aspiration pneumonia as
predominant type in these 38 SAP patients. However, we previously
reported association between human metapneumovirus seropreva-
lence and hypertension in elderly subjects.39 Further, studies including
examination of pathogen(s) are also needed to elucidate precise
mechanism for the association of severe hypertension and SAP.
Table 3 Association of SAP with hypertensive state on admission





risk estimate (95% CI)a P-value
Controlsb 14 1.0
Moderate hypertensives 17 2.36 (0.76–7.29) 0.136
Severe hypertensives 7 2.83 (1.14–7.05) 0.025
Abbreviation: CI, conﬁdence interval.
aAdjusted for age, sex, Glasgow Coma Scale score, WBC, log(serum C-reactive protein) and
dysphagia.
bReference group.
Table 4 Association of SAP death with hypertensive state on





estimate (95% CI)a P-value
Controlsb 21 . 0
Moderate hypertensives 3 2.57 (0.24–27.3) 0.434
Severe hypertensives 3 5.20 (1.01–26.8) 0.049
Abbreviation: CI, conﬁdence interval.
aAdjusted for age, sex, Glasgow Coma Scale score, WBC, log(serum C-reactive protein) and
dysphagia.
bReference group.
Table 5 Association of poor outcome (in-hospital death or artiﬁcial
feeding at discharge) with hypertensive state on admission after





estimate (95% CI)a P-value
Controlsb 91 . 0
Moderate hypertensives 14 2.06 (0.26–16.3) 0.491
Severe hypertensives 5 6.84 (1.32–35.4) 0.022
Abbreviation: CI, conﬁdence interval.
aAdjusted for age, sex, Glasgow Coma Scale score, white blood cell count, log(serum C-reactive
protein) and dysphagia.
bReference group.
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